Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| Anaphylactic shock | Anaphylactic shock | x | x | |||
| Angioedema | Angioedema | x | x | x | ||
| Asthenia | Asthenia | x | x | x | ||
| Cyanosis | Cyanosis | x | x | x | ||
| Haemorrhage | Haemorrhage | x | x | x | ||
| Haemoglobin | Haemorrhage | x | x | x | ||
| Hypersensitivity | Hypersensitivity | x | x | |||
| Nausea | Nausea | x | ||||
| Pruritus | Pruritus | x | x | x | ||
| Pulmonary oedema | Pulmonary oedema | x | x | x | ||
| Hyperhidrosis | Sweating | x | x | x | ||
| Urticaria | Urticaria | x | x | x | ||
| Agitation | Agitation | x | x | x | ||
| Tenderness | Tenderness | x | x | |||
| Throat tightness | Throat tightness | x | x | x | ||
| Induration | Induration | x | x | |||
| Shock | Collapse | x | ||||
| Feeling hot | Sensation of warmth | x | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |